Laboratory Medicine ›› 2025, Vol. 40 ›› Issue (3): 294-298.DOI: 10.3969/j.issn.1673-8640.2025.03.016
Previous Articles Next Articles
LI Yue, LI Li, YANG Chen
Received:2023-11-27
Revised:2024-05-29
Online:2025-03-30
Published:2025-04-10
CLC Number:
LI Yue, LI Li, YANG Chen. Analysis of changes in platelet aggregation rate and D-dimer level in recurrent abortion patients with different times[J]. Laboratory Medicine, 2025, 40(3): 294-298.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2025.03.016
| 组别 | 例数 | 年龄/岁 | 孕前体重指数/(kg·m-2) | 孕周/周 | 最终妊娠结局 | Fib/ (g·L-1) | TT/s | PT/s | APTT/s | |
|---|---|---|---|---|---|---|---|---|---|---|
| 未流产/ [例(%)] | 再次流产/[例(%)] | |||||||||
| 2次组 | 56 | 27.34±2.06 | 22.62±2.78 | 8.45±1.40 | 17(30.36) | 39(69.64) | 1.58±0.45 | 20.90±2.35 | 12.98±1.41 | 25.95±2.76 |
| ≥3次组 | 87 | 27.23±2.35 | 22.58±3.07 | 8.48±1.45 | 24(27.59) | 63(72.41) | 2.86±0.82 | 16.27±1.46 | 10.76±0.83 | 21.40±1.80 |
| 统计值 | 0.286 | 0.079 | 0.122 | 0.128 | 10.683 | 14.541 | 11.850 | 11.940 | ||
| P值 | 0.775 | 0.937 | 0.903 | 0.721 | <0.001 | <0.001 | <0.001 | <0.001 | ||
| 组别 | 例数 | 年龄/岁 | 孕前体重指数/(kg·m-2) | 孕周/周 | 最终妊娠结局 | Fib/ (g·L-1) | TT/s | PT/s | APTT/s | |
|---|---|---|---|---|---|---|---|---|---|---|
| 未流产/ [例(%)] | 再次流产/[例(%)] | |||||||||
| 2次组 | 56 | 27.34±2.06 | 22.62±2.78 | 8.45±1.40 | 17(30.36) | 39(69.64) | 1.58±0.45 | 20.90±2.35 | 12.98±1.41 | 25.95±2.76 |
| ≥3次组 | 87 | 27.23±2.35 | 22.58±3.07 | 8.48±1.45 | 24(27.59) | 63(72.41) | 2.86±0.82 | 16.27±1.46 | 10.76±0.83 | 21.40±1.80 |
| 统计值 | 0.286 | 0.079 | 0.122 | 0.128 | 10.683 | 14.541 | 11.850 | 11.940 | ||
| P值 | 0.775 | 0.937 | 0.903 | 0.721 | <0.001 | <0.001 | <0.001 | <0.001 | ||
| 组别 | 例数 | AA诱导PAgT/% | ADP诱导PAgT/% | DD/ (μg·L-1) |
|---|---|---|---|---|
| 2次组 | 56 | 81.26±7.42 | 80.75±6.24 | 395.57±54.22 |
| ≥3次组 | 87 | 92.54±5.13 | 93.45±4.97 | 492.74±85.63 |
| t值 | 10.748 | 13.477 | 7.566 | |
| P值 | <0.001 | <0.001 | <0.001 |
| 组别 | 例数 | AA诱导PAgT/% | ADP诱导PAgT/% | DD/ (μg·L-1) |
|---|---|---|---|---|
| 2次组 | 56 | 81.26±7.42 | 80.75±6.24 | 395.57±54.22 |
| ≥3次组 | 87 | 92.54±5.13 | 93.45±4.97 | 492.74±85.63 |
| t值 | 10.748 | 13.477 | 7.566 | |
| P值 | <0.001 | <0.001 | <0.001 |
| 指标 | AA诱导PAgT | ADP诱导PAgT | DD | |||||
|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | |||
| Fib | 0.509 | <0.001 | 0.516 | <0.001 | 0.502 | <0.001 | ||
| TT | -0.510 | <0.001 | -0.519 | <0.001 | -0.515 | <0.001 | ||
| PT | -0.492 | <0.001 | -0.492 | <0.001 | -0.487 | <0.001 | ||
| APTT | -0.487 | <0.001 | -0.507 | <0.001 | -0.496 | <0.001 | ||
| 指标 | AA诱导PAgT | ADP诱导PAgT | DD | |||||
|---|---|---|---|---|---|---|---|---|
| r值 | P值 | r值 | P值 | r值 | P值 | |||
| Fib | 0.509 | <0.001 | 0.516 | <0.001 | 0.502 | <0.001 | ||
| TT | -0.510 | <0.001 | -0.519 | <0.001 | -0.515 | <0.001 | ||
| PT | -0.492 | <0.001 | -0.492 | <0.001 | -0.487 | <0.001 | ||
| APTT | -0.487 | <0.001 | -0.507 | <0.001 | -0.496 | <0.001 | ||
| 项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
|---|---|---|---|---|---|
| AA诱导PAgT | 1.093 | 0.327 | 11.178 | 2.984(1.572~5.664) | 0.001 |
| ADP诱导PAgT | 1.069 | 0.335 | 10.186 | 2.913(1.511~5.617) | 0.001 |
| DD | 1.047 | 0.340 | 9.489 | 2.850(1.464~5.550) | 0.002 |
| Fib | 0.017 | 0.132 | 0.016 | 1.017(0.785~1.317) | 0.898 |
| TT | 0.002 | 0.074 | 0.001 | 1.002(0.867~1.158) | 0.978 |
| PT | 0.170 | 0.154 | 1.215 | 1.185(0.876~1.603) | 0.270 |
| APTT | 0.130 | 0.128 | 1.034 | 1.139(0.886~1.464) | 0.309 |
| 项目 | β值 | 标准误 | Wald值 | OR值(95%CI) | P值 |
|---|---|---|---|---|---|
| AA诱导PAgT | 1.093 | 0.327 | 11.178 | 2.984(1.572~5.664) | 0.001 |
| ADP诱导PAgT | 1.069 | 0.335 | 10.186 | 2.913(1.511~5.617) | 0.001 |
| DD | 1.047 | 0.340 | 9.489 | 2.850(1.464~5.550) | 0.002 |
| Fib | 0.017 | 0.132 | 0.016 | 1.017(0.785~1.317) | 0.898 |
| TT | 0.002 | 0.074 | 0.001 | 1.002(0.867~1.158) | 0.978 |
| PT | 0.170 | 0.154 | 1.215 | 1.185(0.876~1.603) | 0.270 |
| APTT | 0.130 | 0.128 | 1.034 | 1.139(0.886~1.464) | 0.309 |
| 组别 | 例数 | AA诱导PAgT/% | ADP诱导PAgT/% | DD/ (μg·L-1) |
|---|---|---|---|---|
| 未流产组 | 41 | 82.73±7.25 | 82.13±6.45 | 384.76±50.81 |
| 再次流产组 | 102 | 90.29±4.78 | 91.03±5.01 | 482.80±80.19 |
| t值 | 7.310 | 8.819 | 7.256 | |
| P值 | <0.001 | <0.001 | <0.001 |
| 组别 | 例数 | AA诱导PAgT/% | ADP诱导PAgT/% | DD/ (μg·L-1) |
|---|---|---|---|---|
| 未流产组 | 41 | 82.73±7.25 | 82.13±6.45 | 384.76±50.81 |
| 再次流产组 | 102 | 90.29±4.78 | 91.03±5.01 | 482.80±80.19 |
| t值 | 7.310 | 8.819 | 7.256 | |
| P值 | <0.001 | <0.001 | <0.001 |
| 影响因素 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | P值 | Youden指数 |
|---|---|---|---|---|---|---|
| AA诱导PAgT | 0.839(0.764~0.913) | 87.42% | 76.52 | 88.45 | <0.001 | 0.650 |
| ADP诱导PAgT | 0.850(0.778~0.922) | 85.46% | 72.55 | 85.41 | <0.001 | 0.580 |
| DD | 0.837(0.772~0.901) | 415.13 μg·L-1 | 74.56 | 82.96 | <0.001 | 0.575 |
| 联合检测 | 0.962(0.933~0.991) | 0.91 | 90.23 | 80.56 | <0.001 | 0.708 |
| 影响因素 | AUC(95%CI) | 最佳临界值 | 敏感性/% | 特异性/% | P值 | Youden指数 |
|---|---|---|---|---|---|---|
| AA诱导PAgT | 0.839(0.764~0.913) | 87.42% | 76.52 | 88.45 | <0.001 | 0.650 |
| ADP诱导PAgT | 0.850(0.778~0.922) | 85.46% | 72.55 | 85.41 | <0.001 | 0.580 |
| DD | 0.837(0.772~0.901) | 415.13 μg·L-1 | 74.56 | 82.96 | <0.001 | 0.575 |
| 联合检测 | 0.962(0.933~0.991) | 0.91 | 90.23 | 80.56 | <0.001 | 0.708 |
| [1] |
自然流产诊治专家共识编写组. 自然流产诊治中国专家共识(2020年版)[J]. 中国实用妇科与产科杂志, 2020, 36(11):1082-1090.
DOI |
| [2] |
DENG T, LIAO X, ZHU S. Recent advances in treatment of recurrent spontaneous abortion[J]. Obstet Gynecol Surv, 2022, 77(6):355-366.
DOI PMID |
| [3] | TANG C, HU W. The role of Th17 and Treg cells in normal pregnancy and unexplained recurrent spontaneous abortion(URSA):new insights into immune mechanisms[J]. Placenta, 2023, 142(1):18-26. |
| [4] | 房书汀, 王东梅. 血栓前状态致复发性流产的中西医研究进展[J]. 中国中医药现代远程教育, 2022, 20(8):205-206. |
| [5] | 陈杰. D-二聚体血小板聚集功能及血栓弹力图联合检测对复发性流产的诊断价值[J]. 中国妇幼保健, 2021, 36(6):1333-1335. |
| [6] | WAUTHIER L, FAVRESSE J, HARDY M, et al. D-dimer testing:a narrative review[J]. Adv Clin Chem, 2023, 114(1):151-223. |
| [7] | 陈灏珠. 实用内科学[M]. 11版. 北京: 人民卫生出版社, 2001. |
| [8] | PIRTEA P, CICINELLI E, DE NOLA R, et al. Endometrial causes of recurrent pregnancy losses:endometriosis,adenomyosis,and chronic endometritis[J]. Fertil Steril, 2021, 115(3):546-560. |
| [9] | YU N, KWAK-KIM J, BAO S. Unexplained recurrent pregnancy loss:novel causes and advanced treatment[J]. J Reprod Immunol, 2023, 155(1):1-13. |
| [10] | GIOULEKA S, TSAKIRIDIS I, ARSENAKI E, et al. Investigation and management of recurrent pregnancy loss:a comprehensive review of guidelines[J]. Obstet Gynecol Surv, 2023, 78(5):287-301. |
| [11] | DONG F, LV Z, DI P. Use of thrombomodulin-modified thrombin generation in uncomplicated pregnancy:the normal range and prothrombotic phenotype[J]. Scand J Clin Lab Invest, 2023, 83(2):79-85. |
| [12] | MARCHI R, DURUAL S, PECHEUX O, et al. Physiological correction of hereditary mild hypofibrinogenemia during pregnancy[J]. Haemophilia, 2023, 29(3):836-843. |
| [13] | 郭盼, 李伟伟, 李荣海, 等. 同型半胱氨酸联合凝血功能检测预测复发性流产研究[J]. 中国医学装备, 2022, 19(8):24-27. |
| [14] | YAO H, JI Y, ZHOU Y. Analysis of blood coagulation indexes,thromboelastogram and autoantibodies in patients with recurrent pregnancy loss[J]. Pak J Med Sci, 2022, 38(7):2005-2010. |
| [15] | 中国人体健康科技促进会生殖免疫专业委员会复发性流产病因检查专家共识编写组. 复发性流产病因检查专家共识[J]. 中国计划生育和妇产科, 2022, 14(2):3-9. |
| [16] | CANG R, HU Z, TIAN Z, et al. Efficacy and safety of the bushen-shugan method in pregnancy outcomes in patients with recurrent miscarriage complicated by anxiety and depression:a prospective randomized trial[J]. Altern Ther Health Med, 2022, 28(6):124-131. |
| [17] | 肖妙妙, 马娴, 王素霞. 多囊卵巢综合征合并复发流产患者孕早期血小板聚集率与子宫动脉血流特点分析[J]. 现代实用医学, 2021, 33(9):1185-1187. |
| [18] | BLOMQVIST L R F, STRANDELL A M, JEPPSSON A, et al. Arachidonic acid-induced platelet aggregation and acetylsalicylic acid treatment during pregnancy in women with recurrent miscarriage,a post hoc study[J]. Platelets, 2022, 33(2):278-284. |
| [19] | 廖晓琼, 汪洪美, 赵富清. 血栓弹力图联合血小板聚集率预测血栓前状态复发性流产结局[J]. 中国计划生育学杂志, 2021, 29(10):2150-2153. |
| [20] | BAO S H, FREMPONG S T, RUAN J L. D-Dimer assay may guide lmwh treatment in repeated biochemical pregnancy losses in women with positive antiphospholipid antibody[J]. Clin Lab, 2020, 66(3):1-13. |
| [21] | BELLESINI M, ROBERT-EBADI H, COMBESCURE C, et al. D-dimer to rule out venous thromboembolism during pregnancy:a systematic review and meta-analysis[J]. J Thromb Haemost, 2021, 19(10):2454-2467. |
| [22] | ZHAO X, TAO H P, WANG C, et al. Changes of anti-β2 glycoprotein I antibody IgA/G/M,platelet aggregation rate,plasma fibrinogen and d-dimer in guiding venous thrombosis during pregnancy[J]. Eur Rev Med Pharmacol Sci, 2021, 25(2):591-597. |
| [23] | YE M, FANG R, LUN S, et al. The association of AT-Ⅲ and D-Dimer with unexplained recurrent spontaneous abortion and their diagnostic value for prethrombotic state[J]. Am J Transl Res, 2022, 14(4):2350-2355. |
| [1] | WANG Xuexing, CHEN Chunmei, HE Yuan, CHU Jie, WEI Chunmei. Roles of thromboelastography and coagulation index in predicting venous thromboembolism in patients with tumors [J]. Laboratory Medicine, 2024, 39(5): 491-496. |
| [2] | LU Wenyuan, XU Jingya, DING Ning. Diagnostic roles of MPV and DD in the severity of acute cerebral infarction at different infarct sites [J]. Laboratory Medicine, 2024, 39(2): 171-175. |
| [3] | GU Yu, LIANG Xiaoyan, MA Shenghui, TONG Na, CHENG Mingyan, YAN Zejun. Expression and near-term prognostic predictive value of plasma biomarkers in chronic kidney disease patients with thromboembolism [J]. Laboratory Medicine, 2023, 38(12): 1177-1182. |
| [4] | HU Bing, LI Gai, ZHANG Huimin. Roles of serum interleukin-6 and D-dimer levels in predicting the risk of cerebral hemorrhage in patients with hypertension [J]. Laboratory Medicine, 2022, 37(1): 63-67. |
| [5] | DING Ning, ZHANG Weifeng, CHEN Xiaoyong, ZHAO Kewen. Correlations of mean platelet volume,D-dimer and fibrinogen degradation product levels with cerebral infarction and its pathological degree [J]. Laboratory Medicine, 2021, 36(4): 384-387. |
| [6] | ZHU Chuanxin, ZHOU Yuping, HE Yan, ZHOU Qin. Diagnostic role of NLR,CRP,PCT,DD and NT-proBNP in severe corona virus disease 2019 [J]. Laboratory Medicine, 2021, 36(2): 190-193. |
| [7] | CHEN Yiming, HUANG Jianxia, SHI Xiaochun, HE Pei, SHEN Yonghai. Diagnostic value of maternal plasma D-dimer and hypertensive disorders of pregnancy in late pregnancy [J]. Laboratory Medicine, 2020, 35(8): 753-756. |
| [8] | LIU Qin, CHEN Chong, YUE Chao. Role of an elevated D-dimer cut-off value for the prognosis of lung cancer [J]. Laboratory Medicine, 2020, 35(8): 763-766. |
| [9] | WANG Bin, YUAN Xu, HAN Feng, TANG Ning. Relevant factors on short-term critical events in patients with corona virus disease 2019 [J]. Laboratory Medicine, 2020, 35(6): 540-545. |
| [10] | CHEN Xing, OU Jingyi, HUANG Ying, TAN Mingkai, CHEN Jiabin, LIN Luping, LIANG Zhiwei, SHI Yaling. Diagnostic roles of several parameters in corona virus disease 2019 [J]. Laboratory Medicine, 2020, 35(4): 295-299. |
| [11] | zhou YE Ping, DONG Xuemei, ZHANG Chong, DU Xiaozhong. Analysis on the results of coagulation four parameters and D-dimer in healthy pregnant women in Lan [J]. Laboratory Medicine, 2020, 35(4): 334-337. |
| [12] | MENG Hongbing, CAO Xingjian, FAN Yuping, GU Shuijing, LI Na. Diagnostic value of D-dimer level in different types of pancreatitis [J]. Laboratory Medicine, 2020, 35(3): 260-263. |
| [13] | ZHENG Wei, HAO Aijun, ZHU Guoyong, ZHANG Yinhui, WANG Dongyun, PANg Jie. Clinical roles of SAA,CRP,LYMPH#,NT-proBNP and DD in COVID-19 [J]. Laboratory Medicine, 2020, 35(12): 1238-1242. |
| [14] | SHANG Xinrong, CHI Lin, SUI Wenjun. Predictive role of plasma D-dimer and fibrinogen degradation product in pre-eclampsia [J]. Laboratory Medicine, 2020, 35(12): 1252-1254. |
| [15] | MA Xiuqing, JIA Haiju, QIN Huiping, MA Huiying, YANG Xingtang, QI Yanxia, LI Shengmei, WANG Chunwei, HE Yujuan. Changes of IL-6 and other 7 indexes in patients with acute cerebral infarction in Qinghai [J]. Laboratory Medicine, 2019, 34(9): 821-825. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||